Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
Rhea-AI Summary
Anika (NASDAQ: ANIK) will issue its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025.
The company will hold a conference call at 8:30 a.m. ET to discuss results and business highlights; dial 1-800-717-1738 (U.S.) or 1-646-307-1865 (international) and use conference ID 53754. A live audio webcast and presentation materials will be available and archived in the Investor Relations section of www.anika.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ANIK gained 3.73%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of the market on Wednesday, November 5, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 53754. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika (NASDAQ: ANIK) release Q3 2025 results?
What time is the Anika Q3 2025 conference call and how do I join?
Where can investors find the Anika Q3 2025 webcast and presentation materials?
Will the Anika Q3 2025 conference call be available after the live event?
What topics will Anika cover on the Q3 2025 call for ANIK shareholders?
